Ignite Creation Date:
2024-05-06 @ 6:47 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05780541
Status:
TERMINATED
Last Update Posted:
2024-02-09
First Post:
2023-03-20
Brief Title:
PF-07304814 for Inpatients With COVID-19 An ACTIV-3TICO Treatment Trial
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Organization Data
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Class:
NIH
Study ID:
014ACTIV-3H6
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Minnesota | OTHER |
| International Network for Strategic Initiatives in Global HIV Trials INSIGHT | NETWORK |
| University of Copenhagen | OTHER |
| Medical Research Council | OTHER_GOV |
| Kirby Institute | OTHER_GOV |
| Washington DC Veterans Affairs Medical Center | FED |
| Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections | NETWORK |
| National Heart Lung and Blood Institute NHLBI | NIH |
| US Department of Veterans Affairs | FED |
| Prevention and Early Treatment of Acute Lung Injury | OTHER |
| Cardiothoracic Surgical Trials Network | OTHER |
| Pfizer | INDUSTRY |